BriaCell Therapeutics BCTX
NASDAQ BCTX
$4.08 -0.08 (-1.81%)
At close: Sep 29, 2026 · 4:00 PM EDT

BriaCell Therapeutics (BCTX) Share-based Compensation (IS) (2021 - 2022)

Updated

BriaCell Therapeutics (BCTX) recorded Share-based Compensation (IS) of $1.59 million in fiscal Q3 2022 (quarter ended Apr 30, 2022), down 21.0% from $2.01 million a year earlier but up 44.1% from the prior quarter.

Analysis

BriaCell Therapeutics (BCTX) Share-based Compensation (IS) (2021 - 2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 BriaCell Therapeutics 30.16 Mn 29.51 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2022 1.59 Mn
Jan 31, 2022 1.10 Mn
Apr 30, 2021 2.01 Mn
API Access

BriaCell Therapeutics Share-based Compensation (IS) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=BCTX&period=max&api_key=YOUR_API_KEY